Cytek Biosciences Adds Flow Cytometry and Imaging Business from DiaSorin | Business | Feb 2023
Cytek Biosciences has signed an agreement with DiaSorin subsidiary Luminex to acquire substantially all of its assets related to the Flow Cytometry an
Stay updated with breaking news from Cell Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytek Biosciences has signed an agreement with DiaSorin subsidiary Luminex to acquire substantially all of its assets related to the Flow Cytometry an
Agilent Technologies Inc has introduced an integrated solution that combines their xCELLigence RTCA HT platform with the BioTek BioSpa 8 Automated Incubator. Click to read more...
24.02.2023 - Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination ...
Data Bridge Market Research analyses that the stem cell therapy market, which is USD 257 million in 2022, is expected to reach USD 921.12 million by 2030,...
Cytek Biosciences partners with Bio-Rad to expand reagent portfolios. The new agreement enhances high-parameter panels on Cytek cell analysis systems